Danisco Introduces HOWARU Restore

The study demonstrated a return to normal baseline levels of this beneficial bacteria immediately following antibiotic therapy. In contrast, a placebo group displayed bifidobacteria levels far below pre-antibiotic therapy.

19/10/06 Antibiotics effectively kill off disease-causing bacteria to the relief of millions of people every year. Yet antibiotics don’t discriminate between beneficial and harmful bacteria, destroying both good and bad alike. Danisco introduces HOWARU™ Restore, a new probiotic formulation clinically proven to maintain and restore healthy gut flora. In fact, a new study shows that antibiotic users are able to restore high levels of beneficial bacteria to pre-antibiotic levels much faster than the body does on its own.

HOWARU Restore promotes the growth of bifidobacteria. The study demonstrated a return to normal baseline levels of this beneficial bacteria immediately following antibiotic therapy. In contrast, a placebo group in the same study displayed bifidobacteria levels far below pre-antibiotic therapy even two weeks after antibiotic cessation.

The second unique result of the study, equally as important, is that the entire population and balance of intestinal microflora was better maintained by taking HOWARU Restore than without it. The research team was able to obtain these results and track the bacterial environment in the gut due to the breakthrough use of new and novel genomic methods of strain tracking and identification.

“This is the first in a line of condition-specific studies by Danisco,” says Scott Bush, Global Probiotics Business Director for Danisco. “Many probiotic suppliers employ a one-strain-does-it-all approach to probiotic efficacy.” Bush continued, “Danisco’s unique screening strategy utilizing in vitro and in vivo models allows selection of the best strain or blend for each condition. This creates products that consumers can be confident will deliver maximum efficacy and an optimum delivery of health benefits.”

Probiotics, or beneficial microflora, form the body’s natural first-line of defense against harmful invaders and help regulate our digestive and immune systems. An imbalance in intestinal microflora resulting from antibiotic therapy can provoke gastrointestinal symptoms such as diarrhea and loose stool, and hypersensitivity such as rash, fever and other allergic reactions that cause the patient pain, discomfort and inconvenience.

Doctors and dietitians typically recommend yogurt to overcome the negative drawbacks of antibiotic therapy. Not all yogurts contain probiotics and when they do, the dosage level is far lower than the strains contained in HOWARU Restore. Pharmacists fill more than 183 million antibiotic prescriptions in the U.S. each year and 900 million globally*. There is a huge consumer market for probiotics which effectively and naturally help maintain gut microflora like HOWARU Restore.

HOWARU Restore is recommended for use in supplements and nutritionals. This particular mixture of probiotic strains from Danisco demonstrates survivability for up to two years in a dry, capsule form.

Danisco markets its exclusive line of premium probiotics, featuring in vitro, in vivo and gold standard human clinical studies, under the HOWARUTM umbrella. HOWARU probiotics offer a wide variety of documented of health benefits. This exclusive probiotic range is backed by Danisco’s global marketing concept designed to educate end users about the benefits of taking a preventative or proactive course of probiotics.

The Probiotics business unit is part of Danisco’s Cultures Division – a global leader in supplying starter cultures, probiotics, media, colors and enzymes, focusing on taste, texture and health functionalities for the nutrition, health and dairy industries.